Prot#CORT125134-455: Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant

Project: Research project

Project Details

StatusActive
Effective start/end date9/25/19 → 9/25/22

Funding

  • ICON Clinical Research Limited (Prot# CORT125134-455)
  • Corcept Therapeutics Incorporated (Prot# CORT125134-455)
View all
View less